Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' FIEVET C' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 66 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Boullier, A; Hennuyer, N; Tailleux, A; Furman, C; Duverger, N; Caillaud, JM; Castro, G; Fievet, C; Fruchart, JC; Duriez, P
      Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-1 with severe hypercholesterolaemia

      CLINICAL SCIENCE
    2. Claudel, T; Leibowitz, MD; Fievet, C; Tailleux, A; Wagner, B; Repa, JJ; Torpier, G; Lobaccaro, JM; Paterniti, JR; Mangelsdorf, DJ; Heyman, RA; Auwerx, J
      Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    3. Davies, PJA; Berry, SA; Shipley, GL; Eckel, RH; Hennuyer, N; Crombie, DL; Ogilvie, KM; Peinado-Onsurbe, J; Fievet, C; Leibowitz, MD; Heyman, RA; Auwerx, J
      Metabolic effects of rexinoids: Tissue-specific regulation of lipoprotein lipase activity

      MOLECULAR PHARMACOLOGY
    4. Morton, NM; Holmes, MC; Fievet, C; Staels, B; Tailleux, A; Mullins, JJ; Seckl, JR
      Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11 beta-hydroxysteroid dehydrogenase type 1 null mice.

      JOURNAL OF BIOLOGICAL CHEMISTRY
    5. Akiyama, TE; Nicol, CJ; Fievet, C; Staels, B; Ward, JM; Auwerx, J; Lee, SST; Gonzalez, FJ; Peters, JM
      Peroxisome proliferator-activated receptor-alpha regulates lipid homeostasis, but is not associated with obesity - Studies with congenic mouse lines

      JOURNAL OF BIOLOGICAL CHEMISTRY
    6. Raspe, E; Duez, H; Gervois, P; Fievet, C; Fruchart, JC; Besnard, S; Mariani, J; Tedgui, A; Staels, B
      Transcriptional regulation of apolipoprotein C-III gene expression by the orphan nuclear receptor ROR alpha

      JOURNAL OF BIOLOGICAL CHEMISTRY
    7. Singaraja, RR; Bocher, V; James, ER; Clee, SM; Zhang, LH; Leavitt, BR; Tan, B; Brooks-Wilson, A; Kwok, A; Bissada, N; Yang, YZ; Liu, GQ; Tafuri, SR; Fievet, C; Wellington, CL; Staels, B; Hayden, MR
      Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and apoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1

      JOURNAL OF BIOLOGICAL CHEMISTRY
    8. Bouly, M; Masson, D; Gross, B; Jiang, XC; Fievet, C; Castro, G; Tall, AR; Fruchart, JC; Staels, B; Lagrost, L; Luc, G
      Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate

      JOURNAL OF BIOLOGICAL CHEMISTRY
    9. Tailleux, A; Labbe, J; Mallet, C; Percevault, F; Fruchart, JC; Fievet, C
      Measurement of rabbit apolipoprotein B by use of electroimmunodiffusion and immunonephelometric assays

      COMPARATIVE MEDICINE
    10. Tailleux, A; Bouly, M; Luc, G; Castro, G; Caillaud, JM; Hennuyer, N; Poulain, P; Fruchart, JC; Duverger, N; Fievet, C
      Decreased susceptibility to diet-induced atherosclerosis in human apolipoprotein A-II transgenic mice

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    11. Leibowitz, MD; Fievet, C; Hennuyer, N; Peinado-Onsurbe, J; Duez, H; Berger, J; Cullinan, CA; Sparrow, CP; Baffic, J; Berger, GD; Santini, C; Marquis, RW; Tolman, RL; Smith, RG; Moller, DE; Auwerx, J
      Activation of PPAR delta alters lipid metabolism in db/db mice

      FEBS LETTERS
    12. Elhage, R; Clamens, S; Reardon-Alulis, C; Getz, GS; Fievet, C; Maret, A; Arnal, JF; Bayard, F
      Loss of atheroprotective effect of estradiol in immunodeficient mice.

      ENDOCRINOLOGY
    13. Chevrier, P; Fievet, C; Ciobanu, SS; Fleurier, C; Scarpa, P
      Study of the arc-electrode interaction in a SF6 self-blast circuit breaker

      JOURNAL OF PHYSICS D-APPLIED PHYSICS
    14. Verite, JC; Boucher, T; Comte, A; Barrault, M; Chevrier, P; Fievet, C
      Coupling between physical arc modelling and circuit modelling in a circuit-breaker

      IEEE TRANSACTIONS ON MAGNETICS
    15. Schoonjans, K; Peinado-Onsurbe, J; Fruchart, JC; Tailleux, A; Fievet, C; Auwerx, J
      3-hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase

      FEBS LETTERS
    16. Mallat, Z; Besnard, S; Duriez, M; Deleuze, V; Emmanuel, F; Bureau, MF; Soubrier, F; Esposito, B; Duez, H; Fievet, C; Staels, B; Duverger, N; Scherman, D; Tedgui, A
      Protective role of interleukin-10 in atherosclerosis

      CIRCULATION RESEARCH
    17. Hennuyer, N; Poulain, P; Madsen, L; Berge, RK; Houdebine, LM; Branellec, D; Fruchart, JC; Fievet, C; Duverger, N; Staels, B
      Beneficial effects of fibrates on apolipoprotein A-I metabolism occur independently of any peroxisome proliferative response

      CIRCULATION
    18. Nion, S; Demoor, L; Boutillon, C; Luchoomun, J; Vanloo, B; Fievet, C; Castro, G; Rosseneu, M; Fruchart, JC; Tartar, A; Clavey, V
      Branched synthetic peptide constructs mimic cellular binding and efflux ofapolipoprotein AI in reconstituted high density lipoproteins

      ATHEROSCLEROSIS
    19. DUEZ HM; MANSEN A; FRUCHART JC; VENNSTROM B; FIEVET C; STAELS B
      REV-ERB-ALPHA - A NUCLEAR RECEPTOR WITH A ROLE IN LIPOPROTEIN METABOLISM

      Circulation
    20. LEFEBVRE AM; PEINADOONSURBE J; LEITERSDORF I; BRIGGS MR; PATERNITI JR; FRUCHART JC; FIEVET C; AUWERX J; STAELS B
      REGULATION OF LIPOPROTEIN METABOLISM BY THIAZOLIDINEDIONES OCCURS THROUGH A DISTINCT BUT COMPLEMENTARY MECHANISM RELATIVE TO FIBRATES

      Arteriosclerosis, thrombosis, and vascular biology
    21. ELHAGE R; ARNAL JF; PIERAGGI MT; DUVERGER N; FIEVET C; FAYE JC; BAYARD F
      17-BETA-ESTRADIOL PREVENTS FATTY STREAK FORMATION IN APOLIPOPROTEIN E-DEFICIENT MICE

      Arteriosclerosis, thrombosis, and vascular biology
    22. IGAU B; CASTRO G; CLAVEY V; SLOMIANNY C; BRESSON R; DROUIN P; FRUCHART JC; FIEVET C
      IN-VIVO GLUCOSYLATED LPA-I SUBFRACTION - EVIDENCE FOR STRUCTURAL AND FUNCTIONAL ALTERATIONS

      Arteriosclerosis, thrombosis, and vascular biology
    23. FIEVET C; BARRAULT M; CHEVRIER P; PETIT P
      EXPERIMENTAL AND NUMERICAL-STUDIES OF ARC RESTRIKES IN LOW-VOLTAGE CIRCUIT-BREAKERS

      IEEE transactions on plasma science
    24. CHEVRIER P; BARRAULT M; FIEVET C; MAFTOUL J; FREMILLON JM
      INDUSTRIAL APPLICATIONS OF HIGH-VOLTAGE, MEDIUM-VOLTAGE AND LOW-VOLTAGE ARC MODELING

      Journal of physics. D, Applied physics
    25. FIEVET C; BARRAULT M; PETIT P; CHEVRIER P; FLEURIER C; ANDRE V
      OPTICAL DIAGNOSTICS AND NUMERICAL MODELING OF ARC RE-STRIKES IN LOW-VOLTAGE CIRCUIT-BREAKERS

      Journal of physics. D, Applied physics
    26. DOMEJEAN E; CHEVRIER P; FIEVET C; PETIT P
      ARC-WALL INTERACTION MODELING IN A LOW-VOLTAGE CIRCUIT-BREAKER

      Journal of physics. D, Applied physics
    27. PETERS JM; HENNUYER N; STAELS B; FRUCHART JC; FIEVET C; GONZALEZ FJ; AUWERX J
      ALTERATIONS IN LIPOPROTEIN METABOLISM IN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA-DEFICIENT MICE

      The Journal of biological chemistry
    28. BOULLIER A; HENNUYER N; DUVERGER N; EMMANUEL F; TAILLEUX A; FIEVET C; DENEFLE P; FRUCHART JC; CASTRO GR; DURIEZ P
      EVOLUTION OF IMMUNOLOGICAL MARKERS OF LDL OXIDATION IN CHOLESTEROL-FED HUMAN APOLIPOPROTEIN AI TRANSGENIC RABBITS

      Atherosclerosis
    29. TAILLEUX A; HENNUYER N; CAILLAUD JM; EMMANUEL F; FRUCHART JC; DUVERGER N; FIEVET C
      PROTECTIVE EFFECT OF HUMAN APO AI OVEREXPRESSION ON ATHEROGENESIS IN TRANSGENIC RABBIT

      Atherosclerosis
    30. LEFEBVRE AM; PEINADOONSURBE J; LEITERSDORF I; BRIGGS MR; PATERNITI JR; FRUCHART JC; FIEVET C; AUWERX J; STAELS B
      THIAZOLIDINEDIONES EXERT A HYPOTRIGLYCERIDEMIC EFFECT BY A DISTINCT, BUT COMPLEMENTARY MECHANISM RELATIVE TO FIBRATES

      Atherosclerosis
    31. LUC G; DUCIMETIERE P; BARD JM; ARVEILER D; EVANS A; CAMBIEN F; FRUCHART JC; FIEVET C
      DISTRIBUTION OF APOLIPOPROTEIN-E BETWEEN APO-B-CONTAINING AND NON-APO-B-CONTAINING LIPOPROTEINS ACCORDING TO APO-E PHENOTYPE

      Atherosclerosis
    32. LEFEBVRE AM; PEINADOONSURBE J; LEITERSDORF I; BRIGGS MR; PATERNITI JR; FRUCHART JC; FIEVET C; AUWERX J; STAELS B
      REGULATION OF LIPOPROTEIN METABOLISM BY THIAZOLIDINE-DIONES OCCURS THROUGH A DISTINCT, BUT COMPLEMENTARY MECHANISM RELATIVE TO FIBRATES

      Atherosclerosis
    33. HENNUYER N; TAILLEUX A; CAILLAUD JM; FRUCHART JC; DENEFLE P; DUVERGER N; FIEVET C
      PROTECTIVE EFFECT OF HUMAN APO A-II OVEREXPRESSION ON ATHEROGENESIS IN TRANSGENIC MICE

      Atherosclerosis
    34. EMMANUEL F; CAILLAUD JM; HENNUYER N; FIEVET C; CASTRO G; FRUCHART JC; HOUDEBINE LM; DENEFLE P; DUVERGER N
      OVEREXPRESSION OF HUMAN APOLIPOPROTEIN-A-I IN TRANSGENIC RABBITS

      Atherosclerosis
    35. DECOSSIN C; CASTRO G; DERUDAS B; BERTRAND M; FRUCHART JC; FIEVET C
      SUBCLASSES OF LPA-I IN CORONARY-ARTERY DISEASE - DISTRIBUTION AND CHOLESTEROL EFFLUX ABILITY

      European journal of clinical investigation
    36. ELHAGE R; BAYARD F; RICHARD V; HOLVOET P; DUVERGER N; FIEVET C; ARNAL JF
      PREVENTION OF FATTY STREAK FORMATION OF 17-BETA-ESTRADIOL IS NOT MEDIATED BY THE PRODUCTION OF NITRIC-OXIDE IN APOLIPOPROTEIN E-DEFICIENT MICE

      Circulation
    37. HENNUYER NM; PETERS JM; STAELS B; FIEVET C; GONZALEZ FJ; AUWERX J
      ROLE OF THE PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR (PPAR) IN HDL METABOLISM - INSIGHTS FROM STUDIES WITH PPAR-ALPHA-DEFICIENT MICE

      Circulation
    38. HENNUYER NM; POULAIN P; MADSEN L; BERGE RK; HOUDEBINE LM; BRANELLEC D; FRUCHART JC; AUWERX J; FIEVET C; DUVERGER N; STAELS B
      THE BENEFICIAL-EFFECTS OF FIBRATES ON HIGH-DENSITY-LIPOPROTEIN METABOLISM OCCUR INDEPENDENT OF ANY PEROXISOME PROLIFERATIVE RESPONSE

      Circulation
    39. CASTRO G; NIHOUL LP; DENGREMONT C; DEGEITERE C; DELFLY B; TAILLEUX A; FIEVET C; DUVERGER N; DENEFLE P; FRUCHART JC; RUBIN EM
      CHOLESTEROL EFFLUX, LECITHIN-CHOLESTEROL ACYLTRANSFERASE ACTIVITY, AND PRE-BETA PARTICLE FORMATION BY SERUM FROM HUMAN APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-A-I APOLIPOPROTEIN A-II TRANSGENIC MICE CONSISTENT WITH THE LATTER BEING LESS EFFECTIVE FOR REVERSE CHOLESTEROL TRANSPORT

      Biochemistry
    40. DUVERGER N; VIGLIETTA C; BERTHOU L; EMMANUEL F; TAILLEUX A; PARMENTIERNIHOUL L; LAINE B; FIEVET C; CASTRO G; FRUCHART JC; HOUBEBINE LM; DENEFLE P
      TRANSGENIC RABBITS EXPRESSING HUMAN APOLIPOPROTEIN-A-I IN THE LIVER

      Arteriosclerosis, thrombosis, and vascular biology
    41. CHEVRIER P; BARRAULT M; FIEVET C
      HYDRODYNAMIC MODEL FOR ELECTRICAL ARC MODELING

      IEEE transactions on power delivery
    42. GUERCI B; IGAU B; ZIEGLER O; CREA T; FRUCHART JC; DROUIN P; FIEVET C
      INTRAPERITONEAL INSULIN INFUSION IMPROVES THE DEPLETION IN CHOLINE-CONTAINING PHOSPHOLIPIDS OF LIPOPROTEIN-B PARTICLES IN TYPE-I DIABETIC-PATIENTS

      Metabolism, clinical and experimental
    43. LUC G; FIEVET C; ARVEILER D; EVANS AE; BARD JM; CAMBIEN F; FRUCHART JC; DUCIMETIERE P
      APOLIPOPROTEIN-C-III AND APOLIPOPROTEIN-E IN APO-B-CONTAINING AND NON-APO-B-CONTAINING LIPOPROTEINS IN 2 POPULATIONS AT CONTRASTING RISK FOR MYOCARDIAL-INFARCTION - THE ECTIM STUDY

      Journal of lipid research
    44. IGAU B; LESTAVEL S; CLAVEY V; SLOMIANNY C; DROUIN P; BRESSON R; FRUCHART JC; DURIEZ P; FIEVET C
      APO B-CONTAINING LIPOPROTEIN PARTICLES IN POORLY CONTROLLED INSULIN-DEPENDENT DIABETES

      Atherosclerosis
    45. DEMOOR L; BOUTILLON C; FIEVET C; VANLOO B; BAERT J; ROSSENEU M; FRUCHART JC; TARTAR A
      BRANCHED SYNTHETIC CONSTRUCTS THAT MIMIC THE PHYSICOCHEMICAL PROPERTIES OF APOLIPOPROTEIN-AI IN RECONSTITUTED HIGH-DENSITY-LIPOPROTEINS

      European journal of biochemistry
    46. EMMANUEL F; CAILLAUD JM; HENNUYER N; FIEVET C; VIRY I; HOUDEBINE LM; FRUCHART JC; DENEFLE P; DUVERGER N
      OVEREXPRESSION OF HUMAN APOLIPOPROTEIN-A-I INHIBITS ATHEROSCLEROSIS DEVELOPMENT IN WATANABE RABBITS

      Circulation
    47. FIEVET C; TALLIEUX A; CAILLAUD JM; FRUCHART JC; DENEFLE P; DUVERGER N
      PROTECTIVE EFFECT OF HUMAN APOA-II OVEREXPRESSION ON ATHEROGENESIS INTRANSGENIC MICE

      Circulation
    48. DUVERGER N; KRUTH H; EMMANUEL F; CAILLAUD JM; VIGLIETTA C; CASTRO G; TAILLEUX A; FIEVET C; FRUCHART JC; HOUDEBINE LM; DENEFLE P
      INHIBITION OF ATHEROSCLEROSIS DEVELOPMENT IN CHOLESTEROL-FED HUMAN APOLIPOPROTEIN A-I-TRANSGENIC RABBITS

      Circulation
    49. VERITE JC; BOUCHER T; COMTE A; DELALONDRE C; ROBINJOUAN P; SERRES E; TEXIER V; BARRAULT M; CHEVRIER P; FIEVET C
      ARC MODELING IN SF6 CIRCUIT-BREAKERS

      IEE proceedings. Science, measurement and technology
    50. TREMP GL; DUCHANGE N; BRANELLEC D; CEREGHINI S; TAILLEUX A; BERTHOU L; FIEVET C; TOUCHET N; SCHOMBERT B; FRUCHART JC; ZAKIN MM; DENEFLE P
      A 700-BP FRAGMENT OF THE HUMAN ANTITHROMBIN-III PROMOTER IS SUFFICIENT TO CONFER HIGH, TISSUE-SPECIFIC EXPRESSION ON HUMAN APOLIPOPROTEIN A-II IN TRANSGENIC MICE

      Gene
    51. FIEVET C; IGAU B; BRESSON R; DROUIN P; FRUCHART JC
      NONENZYMATIC GLYCOSYLATION OF APOLIPOPROT EIN-A-I AND ITS FUNCTIONAL CONSEQUENCES

      Diabete et metabolisme
    52. HARDUIN P; TAILLEUX A; LESTAVEL S; CLAVEY V; FRUCHART JC; FIEVET C
      IMMUNOLOGICAL AND FUNCTIONAL-PROPERTIES OF IN-VITRO OXIDIZED LOW-DENSITY-LIPOPROTEIN

      Journal of lipid research
    53. MEHLUM A; STAELS B; DUVERGER N; TAILLEUX A; CASTRO G; FIEVET C; LUC G; FRUCHART JC; OLIVECRONA G; SKRETTING G; AUWERX J; PRYDZ H
      TISSUE-SPECIFIC EXPRESSION OF THE HUMAN GENE FOR LECITHIN-CHOLESTEROLACYLTRANSFERASE IN TRANSGENIC MICE ALTERS BLOOD-LIPIDS, LIPOPROTEINS AND LIPASES TOWARDS A LESS ATHEROGENIC PROFILE

      European journal of biochemistry
    54. DUVERGER N; TREMP G; CAILLAUD JM; EMMANUEL F; TAILLEUX A; NIHOUL L; FIEVET C; CASTRO G; FRUCHART JC; DENEFLE P
      OVEREXPRESSION OF HUMAN APOLIPOPROTEIN A-IV IN TRANSGENIC MICE INHIBITS ATHEROSCLEROSIS DEVELOPMENT

      Circulation
    55. DECOSSIN C; TAILLEUX A; FRUCHART JC; FIEVET C
      PREVENTION OF IN-VITRO LOW-DENSITY-LIPOPROTEIN OXIDATION BY AN ALBUMIN-CONTAINING LP A-I SUBFRACTION

      Biochimica et biophysica acta, L. Lipids and lipid metabolism
    56. GUERCI B; IGAU B; ZIEGLER O; CREA T; FRUCHART JC; DROUIN P; FIEVET C
      LACK OF RELATIONSHIP BETWEEN LP(A) PARTICLE LEVELS AND ALBUMIN EXCRETION RATE IN TYPE-1 DIABETIC-PATIENTS

      Diabete et metabolisme
    57. CAMPOS E; FIEVET P; CACES E; FRUCHART JC; FIEVET C
      A SCREENING METHOD FOR ABNORMALLY HIGH LIPOPROTEIN(A) CONCENTRATIONS BY AGAROSE LIPOPROTEIN ELECTROPHORESIS

      Clinica chimica acta
    58. CAMPOS E; FIEVET P; CACES E; FRUCHART JC; FIEVET C
      A SCREENING METHOD FOR ABNORMALLY HIGH LIPOPROTEIN(A) CONCENTRATIONS BY AGAROSE LIPOPROTEIN ELECTROPHORESIS

      Clinica chimica acta
    59. TAILLEUX A; CASTRO G; FIEVET C; TREMP G; TOUCHET N; DEGEITERE C; DELFY B; BRITES F; FRUCHART JC; DENEFLE P; DUVERGER N
      EVIDENCE THAT OVEREXPRESSION OF HUMAN APOLIPOPROTEIN A-II IN TRANSGENIC MICE MODULATES REVERSE CHOLESTEROL TRANSPORT

      Circulation
    60. TAILLEUX A; CASTRO G; FIEVET C; TREMP G; TOUCHET N; DEGEITERE C; DELFY B; BRITES F; FRUCHART JC; DENEFLE P; DUVERGER N
      EVIDENCE THAT OVEREXPRESSION OF HUMAN APOLIPOPROTEIN A-II IN TRANSGENIC MICE MODULATES REVERSE CHOLESTEROL TRANSPORT

      Circulation
    61. DUVERGER N; EMMANUEL F; VIGLIETTA C; TAILLEUX A; BENOIT P; ATTENOT F; CUINE S; FIEVET C; LAINE B; FRUCHART JC; HOUBEBINE LM; DENELLE P
      HUMAN APOLIPOPROTEIN-A-I GENE-TRANSFER IN THE RABBIT - INCIDENCE ON ATHEROGENESIS

      Circulation
    62. DUVERGER N; EMMANUEL F; VIGLIETTA C; TAILLEUX A; BENOIT P; ATTENOT F; CUINE S; FIEVET C; LAINE B; FRUCHART JC; HOUBEBINE LM; DENELLE P
      HUMAN APOLIPOPROTEIN-A-I GENE-TRANSFER IN THE RABBIT - INCIDENCE ON ATHEROGENESIS

      Circulation
    63. CIOBANU SS; FLEURIER C; HONG D; FIEVET C
      USE OF THE UV-LIGHT OF A Z-PINCH DISCHARG E FOR DIAGNOSIS OF AN INDUSTRIAL CIRCUIT-BREAKER ARC

      Annales de physique
    64. READE V; TAILLEUX A; READE R; HARDUIN P; CACHERA C; TACQUET A; FRUCHART JC; FIEVET C
      EXPRESSION OF APOLIPOPROTEIN-B EPITOPES IN LOW-DENSITY LIPOPROTEINS OF HEMODIALYZED PATIENTS

      Kidney international
    65. TAILLEUX A; TORPIER G; CARON B; FRUCHART JC; FIEVET C
      IMMUNOLOGICAL PROPERTIES OF APO-B-CONTAINING LIPOPROTEIN PARTICLES INHUMAN ATHEROSCLEROTIC ARTERIES

      Journal of lipid research
    66. FIEVET C; FRUCHART JC
      LIPOPROTEIN PARTICLES AND THEIR DETERMINATION

      Annales de biologie clinique


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/08/20 alle ore 09:19:25